Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity

The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease

(2017) Hozefa Amijee et al.   JOURNAL OF ALZHEIMERS DISEASE

RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In Vivo

(2010) Eugene O’Hare et al.   BEHAVIOURAL BRAIN RESEARCH

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Alzheimer’s Disease Amyloid β-Protein and Synaptic Function

(2009) Tomas Ondrejcak et al.   NEUROMOLECULAR MEDICINE

P2-358: SEN1269: A novel inhibitor of amyloid-beta toxicity

(2008) David I. Scopes et al.   Alzheimers & Dementia

Oligomers of the amyloid-β protein disrupt working memory: Confirmation with two behavioral procedures

(2008) Alan Poling et al.   BEHAVIOURAL BRAIN RESEARCH

Current approaches in the treatment of Alzheimer's disease

(2008) Reena S. Shah et al.   BIOMEDICINE & PHARMACOTHERAPY

Amyloid   Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

(2008) I. Klyubin et al.   JOURNAL OF NEUROSCIENCE

Aggregator compounds confound amyloid fibrillization assay

(2008) Gilbert M Rishton   Nature Chemical Biology

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

(2008) Ganesh M Shankar et al.   NATURE MEDICINE